NYMOX PHARMACEUTICAL CORPORATION (NYMXF) Operating cash flow 2015–2024
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$2.6MFY2024 · since FY2015: -$3.8M → -$2.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$2.6M | +35.9% |
| FY2023 | -$4.1M | +22.1% |
| FY2022 | -$5.2M | +47.0% |
| FY2021 | -$9.8M | +2.2% |
| FY2020 | -$10.0M | -35.1% |
| FY2019 | -$7.4M | +4.8% |
| FY2018 | -$7.8M | -25.7% |
| FY2017 | -$6.2M | -37.8% |
| FY2016 | -$4.5M | -20.0% |
| FY2015 | -$3.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice